Filing Details

Accession Number:
0001144204-13-004838
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-30 16:58:24
Reporting Period:
2013-01-28
Filing Date:
2013-01-30
Accepted Time:
2013-01-30 16:58:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
771856 Champions Oncology Inc. CSBR Biological Products, (No Disgnostic Substances) (2836) 521401755
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1220630 Joel Ackerman C/O Champions Oncology, Inc.
One University Place, Suite 307
Hackensack NJ 07601
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-28 500,000 $0.50 833,333 No 4 P Direct
Common Stock Acquisiton 2013-01-28 28,315 $0.00 861,648 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 J Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to purchase shares of Common Stock Acquisiton 2013-01-28 50,000 $0.00 50,000 $0.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
50,000 2013-01-28 2018-01-28 No 4 A Direct
Footnotes
  1. As a result of the transaction represented in the line above, the 28,315 shares of Common Stock were issued for no consideration pursuant to contractual anti-dilution undertakings of the Issuer in a Securities Purchase Agreement dated March 24, 2011 between the Issuer, the reporting person and certain other investors.
  2. The warrant was acquired in connection with the purchase of shares of Common Stock pursuant to a Securities Purchase Agreement dated January 28, 2013 between the Issuer, the reporting person and certain other investors for no additional consideration.